Bluejay Diagnostics, Inc. Gain (Loss) on Extinguishment of Debt
Bluejay Diagnostics, Inc. (BJDX) reported Gain (Loss) on Extinguishment of Debt of $6.36 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-20.
Discontinued › Expense Statement › Operating Expenses
us-gaap:GainsLossesOnExtinguishmentOfDebt · last filed 2023-03-20
- Bluejay Diagnostics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-12-31 was -$1.36K.
- Bluejay Diagnostics, Inc. gain (loss) on extinguishment of debt for the quarter ending 2021-03-31 was $5.00K.
- Bluejay Diagnostics, Inc. gain (loss) on extinguishment of debt for fiscal 2022 was $6.36K, a 27.20% increase from fiscal 2021.
- Bluejay Diagnostics, Inc. gain (loss) on extinguishment of debt for fiscal 2021 was $5.00K, a 95.10% decline from fiscal 2020.
- Bluejay Diagnostics, Inc. gain (loss) on extinguishment of debt for fiscal 2020 was $102.00K.
| Period end | Gain (Loss) on Extinguishment of Debt 3 month | Gain (Loss) on Extinguishment of Debt 9 month | Gain (Loss) on Extinguishment of Debt 12 month |
|---|---|---|---|
| 2022-12-31 | $6.36K 10-K · filed 2023-03-20 | ||
| 2021-12-31 | -$1.36K derived: 10-K 12 month − 10-Q 9 month · filed 2022-03-10 | $5.00K 10-K · filed 2022-03-10 | |
| 2021-09-30 | $6.36K 10-Q · filed 2021-12-16 | ||
| 2021-03-31 | $5.00K 10-Q · filed 2022-05-09 | ||
| 2020-12-31 | $102.00K 10-K · filed 2022-03-10 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| OSR Health, Inc. (OSRH) | United States | $0.004B | -0.75 |
| Adagio Medical Holdings, Inc. (ADGM) | United States | $0.004B | |
| Autonomix Medical, Inc. (AMIX) | United States | $0.004B | |
| AETHLON MEDICAL INC (AEMD) | United States | $0.005B | |
| INTELLIGENT BIO SOLUTIONS INC. (INBS) | United States | $0.005B | |
| Beyond Air, Inc. (XAIR) | United States | $0.003B | -0.01 |
| Vivos Therapeutics, Inc. (VVOS) | United States | $0.003B | -0.26 |
| Sonoma Pharmaceuticals, Inc. (SNOA) | United States | $0.006B | -2.59 |
| NEXGEL, INC. (NXGL) | United States | $0.002B | |
| INVO Fertility, Inc. (IVF) | United States | $0.002B | -0.71 |